First Header Logo Second Header Logo

Search Result Details

This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to Feldman, Steven
Item TypeName
Academic Article The impact of biologics on the quality of life of psoriasis patients and the economics of psoriasis care.
Academic Article Intermittent dosing of biologics for psoriasis.
Academic Article Novel combination regimens: biologics and acitretin for the treatment of psoriasis-- a case series.
Academic Article Adverse events from systemic therapies for psoriasis are common in clinical practice.
Academic Article Medication adherence and health care costs associated with biologics in Medicaid-enrolled patients with psoriasis.
Academic Article Do utilization management controls for phototherapy increase the prescription of biologics?
Academic Article Increasing use of more potent treatments for psoriasis.
Academic Article Clobetasol propionate spray 0.05% add-on therapy to a stable regimen of biologic treatment in patients with moderate to very severe plaque psoriasis.
Academic Article Medication use and associated health care outcomes and costs for patients with psoriasis in the United States.
Academic Article Would elimination of copayments for phototherapy decrease the cost of treating psoriasis with systemic biologics? A cost analysis.
Academic Article Outcomes associated with the use of biologic agents in moderate to severe psoriasis.
Academic Article Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics.
Academic Article Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 2. Psoriatic arthritis: overview and guidelines of care for treatment with an emphasis on the biologics.
Academic Article Management and costs of severe psoriasis: the role of new biologics.
Academic Article Comparative efficacy of biologics in psoriasis: a review.
Concept Biological Products
Academic Article Adherence to adalimumab in patients with moderate to severe psoriasis.
Academic Article The cost of biologics for psoriasis is increasing.
Academic Article The 5-point Investigator's Global Assessment (IGA) Scale: A modified tool for evaluating plaque psoriasis severity in clinical trials.
Academic Article Biologics and biosimilars.
Academic Article Economic and Comorbidity Burden Among Patients with Moderate-to-Severe Psoriasis.
Academic Article Even well-controlled psoriasis patients have unmet treatment needs regardless of disease severity.
Academic Article Costs of Common Psoriasis Medications, 2010-2014.
Academic Article Review of maintenance of response to psoriasis treatments.
Academic Article Current challenges and emerging drug delivery strategies for the treatment of psoriasis.
Academic Article Dermatologists: Collaborating With Payers to Optimize Coverage Policies.
Academic Article Psoriasis, Depression, and Inflammatory Overlap: A Review.
Academic Article Budget impact model in moderate-to-severe psoriasis vulgaris assessing effects of calcipotriene and betamethasone dipropionate foam on per-patient standard of care costs.
Academic Article Healthcare costs in psoriasis and psoriasis sub-groups over time following psoriasis diagnosis.
Academic Article Severe and acute complications of biologics in psoriasis.
Academic Article Adherence to biologics in patients with psoriasis.
Academic Article Biologics monitoring: incongruity between recommendations and clinician monitoring trends.
Academic Article Adherence and resource use among psoriasis patients treated with biologics.
Academic Article Comparison of the cost-effectiveness of biologic drugs used for moderate-to-severe psoriasis treatment in the United States.
Academic Article The budget impact of brodalumab for the treatment of moderate-to-severe plaque psoriasis on US commercial health plans.
Academic Article Real-world US healthcare costs of psoriasis for biologic-naive patients initiating apremilast or biologics.
Academic Article A systematic review of herpes zoster incidence and consensus recommendations on vaccination in adult patients on systemic therapy for psoriasis or psoriatic arthritis: From the Medical Board of the National Psoriasis Foundation.
Academic Article Patient-reported outcomes are important elements of psoriasis treatment decision making: A discrete choice experiment survey of dermatologists in the United States.
Academic Article Treatment patterns and costs among biologic-naive patients initiating apremilast or biologics for psoriatic arthritis.
Academic Article Tracking the price of existing biologics when drugs enter the market.
Academic Article Relative efficacy of systemic treatments for atopic dermatitis.
Academic Article A safety review of recent advancements in the treatment of psoriasis: analysis of clinical trial safety data.
Academic Article Investigational drugs in phase II clinical trials for moderate to severe plaque psoriasis - potential new treatments on the horizon.
Academic Article Can We Tell Patients That IL-23 and TNF-a Inhibition Are "Natural" Ways to Treat Psoriasis?
Academic Article An update on the topical and oral therapy options for treating pediatric atopic dermatitis.
Academic Article Current biological therapies for use in HIV-positive patients with psoriasis: case report of gesulkumab used and review.
Academic Article The complexity of adverse event assessment and counseling for patients on biologic treatment.
Academic Article The journey for US psoriasis patients prescribed a topical: a retrospective database evaluation of patient progression to oral and/or biologic treatment.
Academic Article Current pharmacological treatment guidelines for psoriasis and psoriatic arthritis.
Academic Article Treatment Adherence and Persistence of Seven Commonly Prescribed Biologics for Moderate to Severe Psoriasis and Psoriatic Arthritis in a U.S. Commercially Insured Population.
Search Criteria
  • Biological Products